Table 1.
Characteristics | Group A Undifferentiated SoloSTARb | Group B Differentiated SoloSTARc | Group C FlexPen |
---|---|---|---|
N | 100 | 100 | 200 |
Males/females (%) | 44/56 | 51/49 | 50/50 |
Age (average) | 50.3 | 49.0 | 48.8 |
Age (%) | |||
18–49 years | 45 | 52 | 50 |
50 years or older | 55 | 48 | 50 |
Diabetes (%) | |||
Type 1 | 20 C | 16 | 12 |
Type 2 | 80 | 84 | 88 A |
Treatment type (%) | |||
Insulin (± OADsd) | 34 | 37 | 36 |
OADs (no insulin) | 66 | 63 | 64 |
Statistical testing: Upper case letter indicates a statistic is significantly higher at the 90% confidence level between groups.
Two participant(s) were color blind.
One participant was color blind.
(OAD) oral antidiabetic drug